A
Acticor Biotech SA
PAR:ALACT
Acticor Biotech SA
PAR:ALACT
Price:
0.25
EUR
Market Closed
Market Cap:
€3.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Acticor Biotech SA
PAR:ALACT
|
FR |
|
Apollo Tourism & Leisure Ltd
ASX:ATL
|
AU |
|
Grendene SA
BOVESPA:GRND3
|
BR |
|
Csam Health Group AS
OSE:CSAM
|
NO |
|
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
ZA |
|
Frasers Centrepoint Trust
OTC:FRZCF
|
SG |
|
Blue Moon Metals Inc
XTSX:MOON
|
CA |
|
Fobi AI Inc
XTSX:FOBI
|
CA |
|
Coppermoly Ltd
ASX:COY
|
AU |
|
Gamehost Inc
TSX:GH
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of ALACT.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALACT
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
ALACT Competitors Multiples
Acticor Biotech SA Competitors
Acticor Biotech SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
A
|
Acticor Biotech SA
PAR:ALACT
|
3.9m EUR | 0 | -0.2 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 89.8 | 14.9 | 20.6 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.8 | 12.4 | 15.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
